Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation

BACKGROUND: Mutations in the TERT promoter, ALK rearrangement, and the BRAF V600E mutation are associated with aggressive clinicopathologic features in thyroid cancers. However, little is known about the impact of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diagn Pathol
Hlavní autoři: Bae, Ja Seong, Kim, Yourha, Jeon, Sora, Kim, Se Hee, Kim, Tae Jung, Lee, Sohee, Kim, Min-Hee, Lim, Dong Jun, Lee, Youn Soo, Jung, Chan Kwon
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746931/
https://ncbi.nlm.nih.gov/pubmed/26857243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0458-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky